ID   GLC-4/CDDP3
AC   CVCL_Y298
SY   GLC4-CDDP3
DR   Wikidata; Q54835917
RX   PubMed=2163989;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0279 ! GLC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 11
//
RX   PubMed=2163989; DOI=10.1002/ijc.2910460125;
RA   Hospers G.A.P., Meijer C., de Leij L.F.M.H., Uges D.R.A., Mulder N.H.,
RA   de Vries E.G.E.;
RT   "A study of human small-cell lung carcinoma (hSCLC) cell lines with
RT   different sensitivities to detect relevant mechanisms of cisplatin
RT   (CDDP) resistance.";
RL   Int. J. Cancer 46:138-144(1990).
//